The Weight of the Status Quo: Reclaiming Life from AFib

For Jon Davies of Edmonton, the decline was not a sudden crash, but a quiet erosion of his capabilities. A man who once spent his time mountain hiking and playing squash, Davies found himself slipping into a state of chronic fatigue in his early 50s. It was a slow withdrawal from the activities that defined his vitality, a shift he initially dismissed as the natural byproduct of a desk job, a lack of exercise, and the onset of old age.

As first reported by Global News Toronto, the reality was far more clinical: atrial fibrillation, or AFib. This common arrhythmia occurs in the upper chambers of the heart and affects between one and two per cent of the general population. While the condition manifests as shortness of breath and fatigue, the stakes are significantly higher, with the potential for heart failure or stroke.

For Davies, the diagnosis brought a crushing realization. When he sought treatment, he was told that his heart had enlarged to such a degree that surgical intervention was no longer a viable option. According to Global News Toronto, Davies was informed he would simply remain on blood thinners. Even after seeking a second opinion, the result remained the same. For years, Davies was forced to accept a "status quo" of diminished capacity.

This sense of desperation is what drives the innovation currently unfolding at Toronto's St. Michael’s Hospital. Dr. Paul Angaran, the hospital's cardiac arrhythmia director, and Dr. Gianluigi Bisleri, the director of minimally invasive and robotic cardiac surgery, have developed a two-part technique to treat patients who may not respond to standard methods.

Traditional catheter ablation involves inserting wires through the groin to the heart to kill tissue around the pulmonary veins, creating tiny scars that block the faulty signals causing the irregular heartbeat. As explained by Dr. Bisleri to Global News Toronto, these scars are created by either overheating or freezing the tissue. However, this standard approach is not effective for every patient.

The new Canadian-first approach combines robotic surgery from the outside of the heart with a subsequent internal catheter technique. Dr. Bisleri notes that the robotic component provides greater dexterity and the ability to treat broader areas of the heart. The process is staggered; patients must wait several weeks or months between the two procedures to allow the external scars to heal, as noted by Dr. Angaran.

Davies, who discovered the procedure through an online search, became one of the first patients to undergo the treatment. He completed the robotic portion in September and is scheduled to return to Toronto for the catheter ablation. Reflecting on the opportunity, Davies told Global News Toronto that it is rewarding to direct his diagnosis toward a more human outcome rather than the alternative of permanent decline.

According to Dr. Angaran, this combined approach could offer a long-term success rate of 70 to 80 per cent for patients suffering from long-standing persistent atrial fibrillation. Despite the potential, Dr. Bisleri told Global News Toronto that awareness of the procedure remains low, even though the referral process is simple.